China Jo-Jo Drugstores Announces $7 Million Registered Direct Offering
China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) announced a definitive agreement with an institutional investor for a registered direct offering of 2,258,888 ordinary shares at a price of $3.10 per share, yielding approximately $7 million in gross proceeds. The agreement also includes warrants for the purchase of up to 4,517,776 additional shares at the same exercise price, valid for five years. The offering is set to close around April 20, 2023, pending customary conditions. Proceeds will be utilized for general corporate purposes and working capital. Maxim Group LLC serves as the placement agent for this offering. This transaction is conducted under a shelf registration statement effective since December 19, 2022.
- Gross proceeds of approximately $7 million from the offering.
- Warrants issued could provide additional capital of up to $14 million if fully exercised.
- Potential dilution of existing shareholders due to new share issuance.
Insights
Analyzing...
Jo-Jo Drugstores intends to use the net proceeds from the offering for general corporate purposes and working capital.
The ordinary shares and warrants described above are being offered pursuant to a "shelf" registration statement on Form F-3 (File No. 333-259692), which was declared effective by the
This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
About
Forward-Looking Statements
This press release contains information about the Company's view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. The Company's encourages you to review other factors that may affect its future results in the Company's annual reports and in its other filings with the
For more information, please contact:
Company Contact:
Chief Financial Officer
+86-571-88077108
frank.zhao@jojodrugstores.com
Investor Relations Contact:
Ascent Investor Relations LLC
+1-917-609-0333
tina.xiao@ascent-ir.com
View original content:https://www.prnewswire.com/news-releases/china-jo-jo-drugstores-announces-7-million-registered-direct-offering-301800393.html
SOURCE
FAQ
What is the purpose of the $7 million offering by CJJD?
When is the closing date for CJJD's direct offering?
What are the terms of the warrants issued in the CJJD offering?
What is the impact of this offering on CJJD's shareholders?
Who is the placement agent for the CJJD offering?
